FindTrial
Sign In

Using PET CT to evaluate residual mucormycosis following surgery

PET CT in assessment of residual mucormycosis after surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/052520
Enrollment
50
Registered
2023-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B461- Rhinocerebral mucormycosis

Interventions

None listed

Sponsors

Maulana Azad Medical College and Associated Lok Nayak Hospital
Lead Sponsor
Dr Ishwar Singh
Collaborator
Dr Ravi Meher
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: PATIENT OF ALL AGE GROUP WHO HAVE UNDERGONE SURGICAL DEBRIDEMENT FOR MUCORMYCOSIS MORE THAN 6 WEEKS EARLIER

Exclusion criteria

Exclusion criteria: PATIENT WITH INTRACRANIAL DISEASE PATIENT WITH DERANGED KIDNEY FUNCTION PATIENT WITH UNCONTROLLED DIABETES MELLITUS

Design outcomes

Primary

MeasureTime frame
ROLE OF PET CT IN ASSESSING THE RESIDUAL MUCORMYCOSIS IN THE HEAD AND NECK REGION AFTER SURGERYTimepoint: 12 MONTHS—

Secondary

MeasureTime frame
nilTimepoint: 0—

Countries

India

Contacts

Public ContactDr Ishwar Singh

Maulana Azad Medical College

drisingh62@gmail.com9953863099

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026